Capital expenditure increased 75.2%
Capital expenditure changed +75.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +75.2% from the comparable as-filed period.
Operating cash-flow margin changed -872 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -1042 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +10.9% from the comparable as-filed period.
Inventory / revenue changed -191 basis points from the comparable as-filed period.
Capex / revenue changed +170 basis points from the comparable as-filed period.
Current liabilities changed +7.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -148.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Total assets changed +6.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Current assets changed +7.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Selling, general & administrative changed +4.3% from the comparable as-filed period.
Working capital changed +9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -2.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -9 basis points from the comparable as-filed period.
Working capital / assets changed +12 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed +14.4% from the comparable as-filed period.
Capital expenditure changed +177.2% from the comparable as-filed period.
Operating income changed +1408.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Free-cash-flow margin changed +1300 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1448 basis points from the comparable as-filed period.
Current liabilities changed +23.6% from the comparable as-filed period.
Stock-based compensation changed +34.6% from the comparable as-filed period.
Capex / revenue changed +148 basis points from the comparable as-filed period.
Total assets changed +13.4% from the comparable as-filed period.
Working capital / assets changed +129 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed +4.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +6.5% from the comparable as-filed period.
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Current ratio changed +2.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +8 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.